{"name":"CastleVax Inc.","slug":"castlevax-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"NDV-HXP-S-KP.2","genericName":"NDV-HXP-S-KP.2","slug":"ndv-hxp-s-kp-2","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"NDV-HXP-S-KP.2","genericName":"NDV-HXP-S-KP.2","slug":"ndv-hxp-s-kp-2","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPSmlZOFE5VDlCZkxsblNiTDgyQzZkcXV6NW5NN1JwMzN3bjZpc29TQS1obWdxbUJBck1nNnNPd254XzI5eEVrX2l0SnpfeWRCUUluU3pOQy05NlZtZWFTbnFoYlVRUTVlQm5fVG1mV0N5U0lVNTU4N0tsLVg4S182RXJ2dnVRR1VfaXZzLXY3cFFvS2VEcUdMSGxSZ1ZkWmttOXlWTldjNXRuOUtLTTFwZUtkbHBPdDZwdUllcVZzdVUwOGY2ckE?oc=5","date":"2026-01-14","type":"trial","source":"Investing.com South Africa","summary":"Aptar’s nasal delivery solutions used in CastleVax COVID-19 vaccine trial By Investing.com - Investing.com South Africa","headline":"Aptar’s nasal delivery solutions used in CastleVax COVID-19 vaccine trial By Investing.com","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxNd29yal9EdkctQnB6eGF6UUQ0MFBHT3lVckpWbjBaYVAtaFhPaXMwVGtQTnRsdU10MHR3X3YyclNDc0YxOGJJaDUtLWlFRU9SWFg1ZDQ5NnFNbFVOSUo1NElRenVBeC11THBNRWN2WXhKOEo0MXFLZlJSblJpUWJib3prTTc4YS04WXJrUEZNUmJfWDlhbUk1WnFnN2dsTVpmMkVycXNSWXFqZ0NhX3RZT01jeVNyYlUxU1NCbV91RHRrSGN0WUFERU5wckFqWWZTbXQtQVZBUGJzdHlRR1J3N2ZmeU9LNHdydTQwNG5IWk9uaGNNSkRUUmszYzR6QUhuSW13R1lFZXpSS29CWDBUNUNQVTA?oc=5","date":"2026-01-13","type":"trial","source":"Business Wire","summary":"Aptar’s Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine Candidate - Business Wire","headline":"Aptar’s Nasal Vaccine Delivery Solutions Featured in CastleVax Phase II Clinical Trial of an Intranasal COVID-19 Vaccine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxOaElBbXo5LTFKbmpYekVUOWtBOTYxdUpoNktNajJLd1JkYTVRZ1lFSFJpMzVJMFBfYW1wZmtpNGx4WkRBRFZZcVNMUVNuQWE3ZEhxcmVjTnliUXFYWUVmMDBsdzNUQk44ak5ZMjZqN1F3aXNxWmhVcVpXWlhzamRTWFFqOHcyeEFJQzgyaGhRaW5kMWpfZG5xY1VEa0xucDRaa3Q0c2tYRi1tQ01aMFp5N0RhVF9SMUJLZHhPZ3FNQlJTWVFSOU81Zk40RHZmcEw5dFB2cW9aZU5jbjNYQUVLMEhhX1l0cDZGak1qaTR0Wk1uaHIzbmdtUjRpcw?oc=5","date":"2025-11-05","type":"trial","source":"BioSpace","summary":"CastleVax Announces Initiation of a Phase 2 Study Evaluating Its Mucosally-delivered, Next Generation, COVID-19 Vaccine Candidate - BioSpace","headline":"CastleVax Announces Initiation of a Phase 2 Study Evaluating Its Mucosally-delivered, Next Generation, COVID-19 Vaccine ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE1JU3JaVTZyaFRsdHVCMV9USWlpa3BmRE55eHVKUDVUWjRVSTBocFFVeHI5RTdNOEpZeWpSSnhBWFNHNjVfQm10cjg1cWg4Yy0yZWxfVzhRUmt5Y3luMDRpRHlxX3hiNWhad1E?oc=5","date":"2025-05-02","type":"pipeline","source":"Labiotech.eu","summary":"5 years later: What happened to COVID vaccine companies? - Labiotech.eu","headline":"5 years later: What happened to COVID vaccine companies?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQb2w1VVg1UkxpWmpvN1lVVUtuRG01dGhXdmFWOXdWVlJ0TmU1ODRTZG4taTdaUGRsX0NpUUU4Slo3TmNFelRwei10SXF0bzF2SDU0YkdmTWtpVC00czRZdEhJbmlEYVJtbzNpckl2MHlWMUhMSGFGREtMTEx0MFZWYjRZa3NPU0JEVXJVS2llMHI?oc=5","date":"2025-04-25","type":"pipeline","source":"C&EN","summary":"US halts funding for new COVID-19 vaccines - C&EN","headline":"US halts funding for new COVID-19 vaccines - C&EN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNM2c1TUdZSU5ndURmN0p4elVpdUJETExoV01WZWE4VER2UE5kaHo0WjEzejhzUHFGU3loS1Q1bGF2UmdtbGtvNDI1cjRfV1RRM3hiSzdRUUh0aFdFb3M4Qmh0YWk0MkN6cmlvRnp5ejNDUnlxWlFnUTFoVWdyMzVJUXN2MkU2MlRyTTV0RkxrYUR5UjlKMWNUa1NXR0pza0dXRUFwbzFfNjk3YjN5Q05xSEtKZ0Jnblp6aUE?oc=5","date":"2022-08-12","type":"pipeline","source":"Fierce Biotech","summary":"Mount Sinai spins out vaccine Castle, preparing to lay siege to infectious diseases - Fierce Biotech","headline":"Mount Sinai spins out vaccine Castle, preparing to lay siege to infectious diseases","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}